Skip to content
Precision for Medicine
Contact Us
Breaking News

Precision Wins Fierce CRO Award for Innovative Solutions in Drug Development

Read more
hero-Clinical-Sample-Logistics-and-Biostorage hero-Clinical-Sample-Logistics-and-Biostorage

Clinical Sample Logistics and Biostorage

The quality of assays can be impacted by inconsistent sample handling – Precision has designed solutions to deliver consistency
Precision uses optimized specimen transport and sample storage processes. Wherever your study is and however long it runs, we safeguard the quality and integrity of your samples to maximize the insight your study delivers.

Precision’s global logistics footprint and comprehensive solutions for biospecimen storage and data provide assurance of sample integrity

Global Processing, Shipment, and Logistics

Our processes follow the sample from collection to analysis.
 
  • Rapid Global PBMC processing
  • Development of customized kitting as needed
  • Export/import permits
  • Late/evening shifts to receive deliveries and resolve shipment issues
  • Knowledge in planning best path for shipment
  • Experience with all major couriers — eg, QuickStat, World Courier, FedEx, Marken

Biospecimen Management

Precision provides sample management and sample accessioning for all sample types. Our biorepositories can store fluid and solid specimens at controlled ambient temperatures, +4°C, -20°C, -80°C, and in liquid nitrogen. Safety features include:
 
  • Redundant backup systems, dedicated backup units
  • Around-the-clock automated temperature monitoring
  • In-house HVAC technicians, specializing in cascade refrigeration
  • Sample accessioning for all sample types: 5-day TAT for full client visibility

Precision Lab e-Portal

With Precision’s Lab e-Portal, sponsors have immediate access to study data, sample inventory data and status, and clinical sample collection kit inventories.

  • Centralized data reporting and analytics available anytime
  • Continuously updated data
  • Sample inventory reports
  • Kit inventory reports
  • Kit expiration data reports

 

 

Biological Storage

Worldwide biospecimen management

Precision’s primary biostorage facility and network of sample processing labs and biorepositories, connected via integrated biospecimen data and management services, safeguard samples around the world.

35 Samples managed
55 With real-time sample processing

Explore Precision’s additional central lab services

Precision’s team provides a suite of services to collect, process, store, and analyze clinical samples collected worldwide.

  • Explore
    kitting

    Clinical Sample Kitting & Logistics

    Kit production, clinical site training, and full sample shipment logistics
    Explore
  • Explore
    sample-processing

    PBMC & Sample Processing

    Sample processing with expertise in PBMC isolations from labs across 5 continents

    Explore
  • Explore

    Biospecimens Data Services

    Purpose-built data systems for specimen management, lab database design, and data reconciliation to ensure data integrity
    Explore

Related resources

 Explore all resources

Explore the Precision blog

Read our blog to gain more insights and discover work that Precision has supported.

Explore our blog
Read: Case Study: Conducting Autologous Cell Therapy Research Across 3 Continents with Zero Sample Loss Case Study: Conducting Autologous Cell Therapy Research Across 3 Continents with Zero Sample Loss

Clinical Trials - Oncology - Cell Therapies

Case Study: Conducting Autologous Cell Therapy Research Across 3 Continents with Zero Sample Loss

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164725548848, hs_child_table_id=0, hs_updated_at=1716454310949, hs_published_at=1748379090824, description=Alexis Hobbins-White is an accomplished leader who plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. She specializes in early phase adaptive studies, particularly in immuno-oncology and advanced therapeutics. She has an MSc in Neuroscience and an MA in Biotechnology Law and Ethics., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Alexis-Hobbins-White-150x150.jpeg',altText='Alexis-Hobbins-White-150x150',fileId=164710912635}, linkedin=https://www.linkedin.com/in/alexis-hobbins-white-400a1720/, lastname=Hobbins-White, hs_initial_published_at=1713362276020, hs_created_by_user_id=5166971, hs_created_at=1713361952861, hs_is_edited=false, hs_deleted_at=0, name=Alexis, job=Senior Director, Operational Strategy , slug=alexis-hobbins-white, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Alexis Hobbins-White avatar

    Alexis Hobbins-White
Discover
Read: Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies

Clinical Trials

Phase 1 Clinical Trial Designs Explained: BOIN, CRM, BLRM & Modern Adaptive Strategies

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1748379090824, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Kurt Preugschat avatar

    Kurt Preugschat
Discover
Read: Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM) Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

Clinical Trials

Phase I Clinical Trial Designs: Continuous Reassessment Method (CRM)

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778891, hs_child_table_id=0, hs_updated_at=1709645745122, hs_published_at=1748379090824, description=Kurt Preugschat has over 11 years of statistical experience from Phase I to Phase IV clinical trials. He is a lead statistician, providing statistical support and oversight for numerous clinical trials associated with new drug applications (NDA), supplemental new drug applications (sNDA), and medical devices. His expertise includes the development of study designs to meet complex clinical questions and the measurement of desired outcomes. In addition, Kurt has extensive experience generating statistical analyses and creating complex SAS programs and macros used by study team., avatar=Image{width=150,height=150,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/kurt-preugschat.webp',altText='',fileId=null}, linkedin=https://www.linkedin.com/in/kurt-preugschat-97298923a, hs_name=, hs_path=, lastname=Preugschat, hs_initial_published_at=1716136551646, hs_created_at=1709645745122, hs_is_edited=false, hs_deleted_at=0, name=Kurt, job=, slug=kurt-preugschat, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Kurt Preugschat avatar

    Kurt Preugschat
Discover